| efficacy of chloroquine in the treatment of plasmodium vivax malaria in turkey. | in most regions of the world, chloroquine (cq) has been the standard treatment for plasmodium vivax malaria for more than 40 years. recently, however, cq-resistant p. vivax has been reported from oceania, several parts of asia, and south america. the therapeutic efficacy of cq in the treatment of acute, p. vivax malaria has now been assessed in two areas of the turkish province of sanliurfa: the towns of karacadag and sekerli. on admission and on days 2, 3, 7, 14, 21, and 28, all 112 patients in ... | 2004 | 15257793 |
| the decreasing efficacy of chloroquine in the treatment of plasmodium vivax malaria, in sanliurfa, south-eastern turkey. | in most regions of the world, chloroquine has been the standard treatment for plasmodium vivax malaria for more than 50 years. recently, however, chloroquine-resistant p. vivax has been reported from oceania, several parts of asia, and south america. in june-august 2004, therapeutic failure following chloroquine treatment of acute p. vivax malaria was investigated among 91 patients from two sites (karacadag and sekerli) in the turkish province of sanliurfa. each patient received a directly obser ... | 2006 | 16492358 |
| malaria in turkey: successful control and strategies for achieving elimination. | turkey is located in the middle of asia, africa and europe, close to caucasia, balkans and middle east in subtropical climate zone. malaria has been known since the early ages of human history and it was one of the leading diseases in anatolian history, as well. today, chloroquine-sensitive plasmodium vivax is the only agent of autochthonous malaria cases in turkey. the other plasmodium species identified are isolated from imported cases of malaria. the most common vector of malaria in turkey is ... | 2011 | 21781952 |